199 related articles for article (PubMed ID: 24036490)
1. Use of peptide thrombopoietin receptor agonist romiplostim (Nplate) in a case of primary HIV-associated thrombocytopenia.
Aslam MI; Cardile AP; Crawford GE
J Int Assoc Provid AIDS Care; 2014; 13(1):22-3. PubMed ID: 24036490
[TBL] [Abstract][Full Text] [Related]
2. Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.
Taylor N; Melchardt T; Grundbichler M; Strasser M; Egle A; Greil R
Ann Hematol; 2013 Jul; 92(7):1001-2. PubMed ID: 23269533
[No Abstract] [Full Text] [Related]
3. Persistent thrombocytopenia post auto-SCT for AML treated with romiplostim in a patient with HIV.
Gangatharan SA; Cooney JP
Bone Marrow Transplant; 2011 Sep; 46(9):1280-1. PubMed ID: 21151181
[No Abstract] [Full Text] [Related]
4. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
[TBL] [Abstract][Full Text] [Related]
5. Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.
Berthelot-Richer M; Boilard B; Morin A; Bolduc B; Beauregard P; Kotb R
Transfusion; 2012 Apr; 52(4):739-41. PubMed ID: 22082044
[TBL] [Abstract][Full Text] [Related]
6. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
Newland A; Godeau B; Priego V; Viallard JF; López Fernández MF; Orejudos A; Eisen M
Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.
Kohn B; Bal G; Chirek A; Rehbein S; Salama A
BMC Vet Res; 2016 Jun; 12():96. PubMed ID: 27283401
[TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
Cantoni N; Heizmann M; Bargetzi M
Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
[No Abstract] [Full Text] [Related]
9. Romiplostim.
Kuter DJ
Cancer Treat Res; 2011; 157():267-88. PubMed ID: 21052962
[TBL] [Abstract][Full Text] [Related]
10. What is the role of novel thrombopoietic agents in the management of acute leukemia?
Kuter DJ
Best Pract Res Clin Haematol; 2016 Dec; 29(4):372-378. PubMed ID: 27890262
[TBL] [Abstract][Full Text] [Related]
11. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
13. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
Tarantino MD; Bussel JB; Blanchette VS; Despotovic J; Bennett C; Raj A; Williams B; Beam D; Morales J; Rose MJ; Carpenter N; Nie K; Eisen M
Lancet; 2016 Jul; 388(10039):45-54. PubMed ID: 27103127
[TBL] [Abstract][Full Text] [Related]
14. A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.
Miao J; Leblebjian H; Scullion B; Parnes A
Am J Hematol; 2018 Aug; 93(4):E86-E88. PubMed ID: 29274130
[No Abstract] [Full Text] [Related]
15. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
Kirito K; Komatsu N
Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
[TBL] [Abstract][Full Text] [Related]
16. Romiplostim.
Cines DB; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2008 Nov; 7(11):887-8. PubMed ID: 18974747
[TBL] [Abstract][Full Text] [Related]
17. Romiplostim for the management of perioperative thrombocytopenia.
Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
[TBL] [Abstract][Full Text] [Related]
18. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors.
Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
Haematologica; 2018 Apr; 103(4):e169-e172. PubMed ID: 29242295
[No Abstract] [Full Text] [Related]
19. Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.
Mahat U; Talati R; Kodish E
Pediatr Blood Cancer; 2019 Jun; 66(6):e27706. PubMed ID: 30854752
[No Abstract] [Full Text] [Related]
20. Romiplostim for the treatment of primary immune thrombocytopenia.
Janssens A
Expert Rev Hematol; 2012 Apr; 5(2):133-44. PubMed ID: 22475281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
